Biology of E1-deleted adenovirus vectors in nonhuman primate muscle

Journal of Virology

Volumn 75, Issue 11, 2001, Pages 5222-5229

  Zoltick, Philip W ^a   Chirmule, Narendra ^a   Schnell, Michael A ^a   Gao, Guang Ping ^a   Hughes, Joseph V ^a   Wilson, James M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GENE PRODUCT; GROWTH HORMONE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS PROTEIN;

ADENOVIRUS; ADOLESCENT; ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC STABILITY; GENETIC TRANSDUCTION; HELPER CELL; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; MUSCLE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ADENOVIRUS E1 PROTEINS; ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; ERYTHROPOIETIN; GENE DELETION; GENE THERAPY; GENETIC VECTORS; GROWTH HORMONE; INJECTIONS, INTRAMUSCULAR; LYMPHOCYTE ACTIVATION; MACACA MULATTA; NEUTRALIZATION TESTS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0035026623     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.11.5222-5229.2001     Document Type: Article

References (42)

1. Battershill, P. E., and S. P. Clissold. 1989. Octreotide: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion. Drugs 38:658-702.
2. Blau, H. M., and M. L. Springer. 1955. Muscle-mediated gene therapy. N. Engl. J. Med. 23:1554-1556.
3. Brody, S. L., and R. G. Crystal. 1994. Adenovirus-mediated in vivo gene transfer. Ann. N.Y. Acad. Sci. 716:90-103.
4. Bromberg, J. S., L. A. Debruyne, and L. Qin. 1998. Interactions between the immune system and gene therapy vectors: bidirectional regulation of response and expression. Adv. Immunol. 69:353-409.
5. Chattergoon, M., J. Boyer, and D. B. Weiner. 1997. Genetic immunization: a new era in vaccines and immune therapeutics. FASEB J. 11:753-763.
6. Chen, H. H., L. M. Mack, R. Kelly, M. Ontell, S. Kochanek, and P. R. Clemens. 1997. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. USA 94:1645-1650.
7. Chirmule, N., J. V. Hughes, G.-P. Gao, S. E. Raper, and J. M. Wilson. 1998. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J. Virol. 72:6138-6145.
8. Crystal, R. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404-410.
9. Dai, Y., E. Schwartz, D. Gu, W. Zhang, N. Sarvetnick, and I. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
10. Engelhardt, J., X. Ye, B. Doranz, and J. Wilson. 1994 Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196-6200.
11. Engelhardt, J. F., R. H. Simon, Y. Yang, M. Zepeda, S. W. Pendleton, B. Doranz, M. Grossman, and J. M. Wilson. 1993. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum. Gene Ther. 4:759-769.
12. Gao, G. P., Y. Yang, and J. M. Wilson. 1996. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70:8934-8943.
13. Golos, T. G., M. Durning, J. M. Fisher, and P. D. Fowler. 1993. Cloning of four growth hormone/chorionic somatomammotropin-related complementary deoxyribonucleic acids differentially expressed during pregnancy in the rhesus monkey placenta. Endocrinology 133:1744-1752.
14. Ilan, Y., P. Attavar, M. Takahashi, A. Davidson, M. S. Horwitz, J. Guida, N. R. Chowdhury, and J. R. Chowdhury. 1996. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. J. Clin. Investig. 98:2640-2647.
15. Ilan, Y., V. K. Jona, K. Sengupta, A. Davidson, M. S. Horwitz, N. Roy-Chowdhury, and J. Roy-Chowdhury. 1997. Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat. Hepatology 26:949-956.
16. Inui, K., S. Okada, and G. Dickson. 1996. Gene therapy in Duchenne muscular dystrophy. Brain Dev. 18:357-361.
17. Jacoby, J. H., J. F. Sassin, M. Greenstein, and E. D. Weitzman. 1974. Patterns of spontaneous cortisol and growth hormone secretion in rhesus monkeys during the sleep-waking cycle. Neuroendocrinology 14:165-173.
18. Jooss, K., H. C. Ertl, and J. M. Wilson. 1998. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J. Virol. 72:2945-2954.
19. Jooss, K., L. A. Turka, and J. M. Wilson. 1998. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig. Gene Ther. 5:309-319.
20. Kaplan, J. M., and A. E. Smith. 1997. Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung. Hum. Gene Ther. 8:1095-1104.
21. Karpati, G., and G. Acsadi. 1993. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases. Muscle Nerve 16:1141-1153.
22. Kass-Eisler, A., E. Falck-Pedersen, D. H. Elfenbein, M. Alvira, P. M. Buttrick, and L. A. Leinwand. 1994. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1:395-402.
23. Lee, W. C., Y. H. Wan, W. Li, F. Fu, P. J. Sime, J. Gauldie, A. W. Thomson, J. J. Fung, L. Lu, and S. Qian. 1999. Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGF beta 1. Transplant Proc. 31:1195.
24. Marshall, D. J., and J. M. Leiden. 1998. Recent advances in skeletal-muscle-based gene therapy. Curr. Opin. Genet. Dev. 8:360-365.
25. Morsy, M. A., M. Gu, S. Motzel, J. Zhao, J. Lin, Q. Su, H. Allen, L. Franlin, R. J. Parks, F. L. Graham, S. Kochanek, A. J. Bett, and C. T. Caskey. 1998. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc. Natl. Acad. Sci. USA 95:7866-7871.
26. Natelson, B. H., J. Holaday, J. Meyerhoff, and P. E. Stokes. 1975. Temporal changes in growth hormone, cortisol, and glucose: relation to light onset and behavior. Am. J. Physiol. 229:409-415.
27. Pretolani, M. 1999. Interleukin-10: an anti-inflammatory cytokine with therapeutic potential. Clin. Exp. Allergy 29:1164-1171.
28. Quantin, B., L. D. Perricaudet, S. Tajbakhsh, and J.-L. Mandel. 1992. Adenovirus as an expression vector in muscle cell in vivo. Proc. Natl. Acad. Sci. USA 89:338-340.
29. Ragot, T., N. Vincent, P. Chafey, E. Vigne, H. Gilgenkrantz, D. Couton, J. Cartaud, P. Briand, J. C. Kaplan, M. Perricaudet, and A. Kahn. 1993. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361:647-650.
30. Smith, T. A., B. D. White, J. M. Gardner, M. Kaleko, and A. McClelland. 1996. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther. 3:496-502.
31. Svensson, E. C., H. B. Black, D. L. Dugger, S. K. Tripathy, E. Goldwasser, Z. Hao, L. Chu, and J. M. Leiden. 1997. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum. Gene Ther. 8:1797-1806.
32. Thomas, C. E., G. Schiedner, S. Kochanek, M. G. Castro, and P. R. Lowenstein. 2000. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases. Proc. Natl. Acad. Sci. USA 97:7482-7487.
33. Tripathy, S. K., B. H. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550.
34. van Ginkel, F. W., J. R. McGhee, C. Liu, J. W. Simecka, M. Yamamoto, R. A. Frizzell, E. J. Sorscher, H. Kiyono, and D. W. Pascual. 1997. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J. Immunol. 159:685-693.
35. Vincent, N., T. Ragot, H. Gilgenkrantz, D. Couton, P. Chafey, A. Gregoire, P., Briand, J. C., Kaplan, M. Petticaudet, and A. Kahn. 1993. Long term correction of mouse dystrophic degenration by adenovirus transfer of a mini-dystrophin gene. Nat. Genet. 5:130-134.
36. Wilson, J., D. Foster, H. Kronenberg, and P. Larsen. 1998. Williams textbook of endocrinology, 9th ed. W. B. Saunders, Philadelphia, Pa.
37. Yang, Y., H. C. J. Ertl, and J. M. Wilson. 1994. MHC class I restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
38. Yang, Y., S. Haecker, Q. Su, and J. Wilson. 1996. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum. Mol. Genet. 5:1703-1712.
39. Yang, Y., K. Jooss, Q. Su, H. C. J. Ertl, and J. M. Wilson. 1995. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3:137-144.
40. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:362-369.
41. Yang, Y., Z. Xiang, H. C. Ertl, and J. M. Wilson. 1995. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:7257-7261.
42. Ye, X., V. M. Rivera, P. Zoltick, F. Cerasoli, M. A. Schnell, G. P. Gao, J. V. Hughes, M. Gilman, and J. M. Wilson. 1999. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 283:88-91.